INT-767 reversed HFD-induced obesity dependent on activation of both TGR5 and FXR and also reversed the development of atherosclerosis and non-alcoholic fatty liver disease (NAFLD). The gene discussed is GPBAR1; the disease is metabolic dysfunction-associated steatotic liver disease.